glp 1 agonists approved for weight loss Comparing GLP-type therapies in those without diabetes. Two glucagon-like peptide-1 receptor (GLP-1 RAs) (#semaglutide and #liraglutide) and one dual agonist (#tirzepatide) have been FDA-approved for #weightloss in adults Which GLP-1 Agonist is Best
Description
This means their quality, purity, and efficacy are not held to the same standards as licensed pharmaceuticals
In SUSTAIN-6 trial similar effects in MACE risk reduction, glycemic control and hypoglycemia rates were observed in patients receiving 0.5 mg semaglutide once weekly and in those receiving 1 mg once weekly (43)
Drucker the 2020 Warren Alpert Foundation Prize
doi: 10.1016/S1474-4422(24)00097-8
